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1. Introduction 
Glycerol 3-phosphate dehydrogenase (glycerol 
3-phosphate:NAD oxidoreductase, EC 1.1.1.8) is a 
soluble NAD-linked enzyme which catalyzes the 
interconversion of dihydroxyacetone phosphate 
and L-o-glycerol 3-phosphate [ 1,2]. It has been 
reported that several enzymes whose natural 
substrates are the phosphorylated derivatives also 
act on the non-phosphorylated analogs if arsenate 
is present [3]. A kinetic study of the effect of 
arsenate on the activity of glucose phosphate 
isomerase (EC 5.3.1.9) when fructose is used as 
substrate [4] suggests that, subsequent to the 
binding of arsenate by the enzyme, fructose is 
bound, following which an interaction occurs 
between arsenate and the hydroxyl group of 
fructose, yielding an ester-like compound capable 
of substituting for the homologous phosphate 
ester fructose 6-phosphate. 
Furthermore, studies of the effects of inorganic 
arsenate on the reactions catalyzed by purified 
enzymes in which inorganic phosphate is a 
reactant, have provided results suggesting that 
inorganic arsenate reacts to form an arsenylated 
intermediate that is unstable in aqueous systems 
[5]. This paper reports results obtained in a study 
of the effect of arsenate on the glycerol 3-phosphate 
dehydrogenase-mediated reduction of dihydroxy- 
acetone, The evidence obtained suggests that, at 
least in this case, an ester-like compound is formed 
between DHA and arsenate without involvement 
of the enzyme active site. The resulting analog is 
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acted upon by the enzyme in a manner similar to 
that for the phosphorylated substrate. 
2. Materials and methods 
L-o_-Glycerolphosphate dehydrogenase from 
rabbit skeletal muscle (spec. act. 180 units/mg, 
pH 7.5,25”C) and Tris-HCl were purchased from 
Sigma, St Louis. Dihydroxyacetone phosphate as 
the dimethylketal dicyclohexylammonium salt, 
NAD’, NADH (disodium salt) and triethanolamine- 
HCl were obtained from Boehringer-Mannheim. 
Dihydroxyacetone and 3-hydroxy-2-butanone were 
from Eastman Kodak, Rochester, NY; hydroxy-2- 
propanone from Pfaltz-Bauer, Flushing, NY; sodium 
arsenate and 1 ,Zpropanediol from Fisher Scientific, 
NJ; cyclohexanone was from Rhone-Poulenc, France. 
74As as sodium arsenate, was obtained from the 
Radibchemical Centre, Amersham, England. All other 
reagents were the best available grade. 
Enzyme activity was measured as described 
previously [6]. The stopped-flow experiments were 
carried out in a Durrum Spectrophotometer, model 
D-160, at 25°C. Proton nuclear magnetic resonance 
spectra were obtained with a Varian XL-1 00 NMR 
Spectrometer, using tetramethylsilane as internal 
standard. Labile protons of the samples were 
exchanged with deuterium through repeated solution- 
evaporation in Da0 (99.98%). Three-times recrystal- 
lized dihydroxyacetone was used throughout. The 
possibility of binding of arsenate to the enzyme was 
checked by gel filtration as described by Hummel 
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and Dreyer [7] using 73As (as sodium arsenate). The 
method of Wilkinson [8] was used for calculation of 
the kinetic parameters. Fluorometric titration of the 
binding of NADH to glycerol 3-phosphate dehydro- 
genase was done in an Aminco-Bowman spectro- 
fluorimeter. The data was subjected to a modified 
Scatchard analysis [9] in order to evaluate the 
number of binding sites and the dissociation 
constant. 
3. Results and discussion 
When dihydroxyacetone is used as a substrate for 
GPDH, no reaction can be detected unless arsenate 
is present in the reaction mixture. Furthermore, 
DHA probably does not bind to the enzyme in the 
absence of arsenate, as suggested by the fact that no 
inhibition of the reaction with the phosphorylated 
substrate (DHAP), is observed in the presence of the 
non-phosphorylated analog. Increasing arsenate 
concentration increases the rate of catalysis and, 
as shown in fig. 1, saturation is obtained at about 
120 mM arsenate. 
At saturating concentrations of arsenate (270 mM), 
the plot of initial velocity versus DHA concentration 
displays a Michael-Menten pattern (fig.2). A similar 
pattern was obtained when NADH was the varied 
substrate. The calculated Km app. for DHA is 64 mM, 
Km app. for NADH 15 PM and Km app. for arsenate 
was 27 mM. The value of 64 mM for DHA in the 
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Fig. 1. Effect of arsenate on the enzymatic reduction of DHA 
catalyzed by GPDH. DHA concentration was 270 mM, 
NADH was 40 PM, Tris-HC150 mM, pH 7.5, 25°C. 
Fig.2. Velocity versus substrate curve for the enzymatic 
reduction of DHA by GPDH. NADH concentration was 
40 PM, Tris-HC150 mM, pH 7.5, 25°C. (o-o) Without 
arsenate; (o-o) 270 mM arsenate. 
presence of arsenate is about 30-times higher than 
previously published values for the phosphorylated 
substrates [6,10,1 I]. The value of Km app. for NADH 
is close to the values reported for the reaction with the 
phosphorylated substrate [6,10,11]. 
The dependence of the initial rate of reaction on 
pH, for the enzymatic reduction of DHA in the 
presence of arsenate is shown in fig.3. The optimum 
pH app. of 7.3 is very close to the pH optimum (7.5) 
for the enzymatic reduction of DHAP [ 121. 
These results suggest hat when arsenate is present, 
the enzymatic reduction of DHA follows a kinetic 
Fig.3. pH-Rate profile for GPDH-catalyzed reduction of 
dihydroxyacetone in the presence of 200 mM arsenate and 
50 PM NADH. GPDH concentration was 5 ug/ml, 25°C; 
pH-Range 6-7, Triethanolamine-HCI; pH-range 7.2-8.5, 
Tris- HCl. 
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Fig.4. Modified Scatchard plot for the enhancement of 
fluorescence as NADH is bound to GPDH. Enzyme 
concentration was 7.7 PM, 25°C. (0-e) No arsenate 
present; (A-A) in the presence of 190 mM arsenate. 
Tris-HCl 50 mM, pH 7.5. 
pattern similar to that for the reduction of DHAP. 
The principal difference is that the substrate inhibi- 
tion observed with the phosphorylated substrate [ 131 
is not present when the non-phosphorylated analog 
is used. Other substrate analogs tested such as 
hydroxy-2-propanone, 3-hydroxy-2-butanone and 
1,2-propanediol showed no reactivity even in the 
presence of arsenate. 
Gel filtration experiments designed to study the 
possibility of a direct effect of arsenate on the 
enzyme showed that, even at concentrations of 
arsenate beyond saturating ones (up to 0.5 M), there 
is no detectable binding of the anion to the protein. 
This is also true in the presence of DHA. These 
results and the fact that neither the number of sites 
nor the dissociation constant for NADH are altered 
by arsenate (fig.4) suggested that arsenate may be 
acting on the substrate, DHA, directly, or through 
a ternary complex (AS-E-DHA), but not on the 
enzyme. 
These two alternatives were clearly differentiated 
in the stopped-flow experiments. When arsenate is 
placed in the same syringe with the enzyme and 
NADH, the reaction exhibits a lag phase before 
becoming zero-order (figSa). However, when 
arsenate and dihydroxyacetone are mixed together 
in the same syringe, this lag phase is not observed; 
the plot of product formation versus time is linear 
from the beginning (fig.Sb). This result strongly 
Fig.& Progress curves for GPDH-catalyzed reduction of 
dihydroxyacetone in the presence of arsenate. [DHA] 
250 mM, [NADH] 36 PM, [arsenate] 250 M, GPDH 
1 PM. Tris-HCl SO mM, pH 7.5. Ordinate, 0.5 V/div; 
Abscissa, 0.1 seg/div. (A) Arsenate and DHA in separate 
syringes. (B) Arsenate and DHA in the same syringe. 
Table 1 
Stopped-flow kinetics experiments 
Syringe 1 Syringe 2 Curve observed 
DHA, GPDH, NADH 
GPDH, DHA 
GPDH, Arsenate 
GPDH 
GPDH, NADH, Arsenate 
Arsenate With lag 
Arsenate, NADH With lag 
DHA, NADH With lag 
DHA, Arsenate, NADH Zero order 
DHA, Arsenate Zero order 
After mixing the solutions from syringes 1 and 2, the light absorption was 
measured, indicating the appearance of NAD. Graphs are in figs.4 and 5 
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suggests that au adduct between DHA and arsenate 
must be formed in order to generate a suitable 
enzyme substrate. Other combinations were also 
tested, and the results, summarized in table 1, 
support this conclusion. 
Formation of the As-DHA adduct seems to be 
a spontaneous reaction by which an ester-like 
product is probably formed. 
Nuclear magnetic resonance studies of the 
interaction of arsenate and DHA (both compounds 
used at 10% concentration by weight) show that 
the NMR spectrum of DHA changes significantly 
upon addition of arsenate. The main change 
observed is a shift of the signal from the a-protons 
of DHA by 0.1 ppm toward higher frequency. 
When phosphate is used instead of arsenate, 
no detectable change in the NMR spectrum is 
observed. The lack of effect of phosphate is in 
Lgreement with the fact that this anion does not 
promote any detectable activity when used with 
the nonphosphorylated analog of the substrate. 
The experimental results described strongly 
suggest hat the nzymatic reduction of dihydroxy- 
acetone, catalyzed by L-a-glycerol 3-phosphate 
dehydrogenase in the presence of arsenate, is 
mediated by the spontaneous formation of a 
DHA-arsenate complex, which is then recognized 
by the enzyme as a substrate. 
Acknowledgments 
The authors are indebted to Dr E. H. Cordes for 
reading the manuscript and making useful suggestions. 
This work was supported in part by Grant No. 
Sl-0354 from the Consejo National de Investigaciones 
Cientificas y Tecnol6gicas (CONICIT). Thanks are due 
to Mrs A. Istok for her secretarial work. 
References 
[l] Baranowski, T. (1963) in: The Enzymes, Vol. 7, 
pp. 85-94, Academic Press, New York. 
[2] Apitz-Castro, R. (1972) in: Molecular Basis of 
Biological Activity, pp. 77-101, Academic Press 
Inc., New York. 
[ 31 Lagunas, R. and Sols, A. (1968) FEBS Lett. 1, 32-34. 
[4] Lagunas, R. (1970) Biochim. Biophys. Acta 220, 
108-115. 
[S] Slocum, D. H. andvarner, J. E. (1960) J. Biol. Chem. 
235,492-495. 
[6] Apitz-Castro, R., Ryder, E. and Gaede, K. (1964) 
Acta Cient. Venezolana 15, 177-183. 
[7] Hummel, J. P. and Dreyer, W. .I. (1962) Biochim. 
Biophys. Acta 63, 530-532. 
[8] Wilkinson, G. N. (1961) Biochem. J. 80, 324-332. 
[9] Gutfreund, H. (1972) in: Enzymes: Physical 
Principles, pp. 70-72, Wiley-Interscience, London. 
[lo] Black, W. J. (1966) Can. J. Biochem. 44, 1301-i317. 
[ 1 l] Young, H. L. and Pace, N. (1958) Arch. Biochim. 
Biophys. 75,125-141. 
1121 Apitz-Castro, R. and Suarez, Z. (1970) Biochim. 
Biophys. Acta 198, 176-182. 
[13] Apitz-Castro, R. and Suarez, Z. (1969) Biochim. 
Biophys. Acta 185, 258-260. 
118 
